Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
Recruiting · NCT05669534 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP | AIDS, Blood-Borne Infections, Chemically-Induced Disorders, Cognition Disorders, Cognitive Dysfunction, Genital Diseases, HIV infectious disease, Infections, Narcotic-Related Disorders, Opioid Use Disorder, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, cognitive disorder, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, opiate dependence, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 4 | 2026-06-15 | NCT05669534 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Connecticut | 40 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APT Foundation | New Haven | United States | 1 |